Abstract
Aims—To explore the correlation between the cagA status of Helicobacter pylori and the density and topographic localisation of H pylori.
Methods—Gastric antral biopsy specimens were taken from 716 consecutive patients, including 293 H pylori positive patients (124 men, 169 women; mean age, 52.6 years; range, 12–87). A serum sample was taken for determination of IgG anti-CagA antibodies (sensitivity of 94.4% and specificity of 92.5%). The density of H pylori was assessed semiquantitatively (grades I–IV) in biopsy specimens stained with the modified Giemsa stain. Topographic localisation was classified as follows: score A, H pylori closely attached to the mucosa; score B, H pylori attached to the mucosa and in the mucus; and score C, H pylori solely in the mucus.
Results—CagA antibodies were present in 154 (52.5%) of the patients. There was no significant difference in colonisation density and cagA status: grade I, 23 (14%); grade II, 78 (50.6%); grade III, 42 (27.5%); and grade IV, 11 (7.2%) in the cagA+ strains and 29 (21.2%), 57 (40.8%), 38 (27%), and 15 (11%), respectively, in the cagA- strains. There was no difference in topographic localisation between cagA+ and cagA-H pylori. Mean anti-CagA titres were 0.84, 0.84, 0.89, and 0.73 in patients with grades I–IV bacterial density, respectively.
Conclusion—Antibody titres do not correlate with H pylori density and there is no difference in density between cagA+ and cagA-H pylori strains. In addition there is no difference in topographic localisation between cagA+ and cagA- H pylori strains.
Key Words: Helicobacter pylori topography • Helicobacter pylori colonisation • density • antibody titres
Full Text
The Full Text of this article is available as a PDF (95.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med. 2000 Feb 21;191(4):593–602. doi: 10.1084/jem.191.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Atherton J. C., Tham K. T., Peek R. M., Jr, Cover T. L., Blaser M. J. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis. 1996 Sep;174(3):552–556. doi: 10.1093/infdis/174.3.552. [DOI] [PubMed] [Google Scholar]
- Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995 May 15;55(10):2111–2115. [PubMed] [Google Scholar]
- Loffeld R. J., Stobberingh E., Arends J. W. A review of diagnostic techniques for Helicobacter pylori infection. Dig Dis. 1993;11(3):173–180. doi: 10.1159/000171409. [DOI] [PubMed] [Google Scholar]
- Loffeld R. J., Stobberingh E., Flendrig J. A., van Spreeuwel J. P., Arends J. W. Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet. 1989 May 27;1(8648):1182–1185. doi: 10.1016/s0140-6736(89)92761-x. [DOI] [PubMed] [Google Scholar]
- Loffeld R. J., Werdmuller B. F., Kusters J. G., Kuipers E. J. IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains. FEMS Immunol Med Microbiol. 2000 Jun;28(2):139–141. doi: 10.1111/j.1574-695X.2000.tb01468.x. [DOI] [PubMed] [Google Scholar]
- Mirshahi F., Fowler G., Patel A., Shaw G. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity. J Clin Pathol. 1998 Mar;51(3):220–224. doi: 10.1136/jcp.51.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakshabendi I. M., Zhang Q. B., Mokhashi M., Gemmell C. G., Lee F. D., Russell R. I. Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer. Helicobacter. 1996 Sep;1(3):155–158. doi: 10.1111/j.1523-5378.1996.tb00030.x. [DOI] [PubMed] [Google Scholar]
- Peña A. S., Endtz H. P., Offerhaus G. J., Hoogenboom-Verdegaal A., van Duijn W., de Vargas N., den Hartog G., Kreuning J., van der Reyden J., Mouton R. P. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion. 1989;44(3):131–141. doi: 10.1159/000199902. [DOI] [PubMed] [Google Scholar]
- Potters H. V., Loffeld R. J., Stobberingh E., van Spreeuwel J. P., Arends J. W. Rapid staining of Campylobacter pyloridis. Histopathology. 1987 Nov;11(11):1223–1223. doi: 10.1111/j.1365-2559.1987.tb01863.x. [DOI] [PubMed] [Google Scholar]
- Sasayama Y., Kawano S., Tsuji S., Fusamoto H., Kamada T., Fukui H., Yoneda S., Okishio T. Relationship between interleukin-8 levels and myeloperoxidase activity in human gastric mucosa. J Gastroenterol Hepatol. 1997 Feb;12(2):104–108. doi: 10.1111/j.1440-1746.1997.tb00392.x. [DOI] [PubMed] [Google Scholar]
- Segal E. D., Cha J., Lo J., Falkow S., Tompkins L. S. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14559–14564. doi: 10.1073/pnas.96.25.14559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weel J. F., van der Hulst R. W., Gerrits Y., Roorda P., Feller M., Dankert J., Tytgat G. N., van der Ende A. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996 May;173(5):1171–1175. doi: 10.1093/infdis/173.5.1171. [DOI] [PubMed] [Google Scholar]